Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Jaguar Health, Inc. on November 10, 2020. The filing serves as a Regulation FD disclosure to announce an upcoming conference call scheduled for November 16, 2020, to review third-quarter 2020 financial results and provide business updates.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding a future event rather than a financial report containing quantitative data.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The document solely references the upcoming release of third-quarter 2020 financials.
Guidance, Outlook, and Management Commentary
Management has scheduled a conference call for November 16, 2020, at 8:30 a.m. ET to discuss third-quarter 2020 financials and business updates. The press release accompanying this filing is furnished as Exhibit 99.1 but is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the date and time of the third-quarter 2020 earnings conference call (November 16, 2020, 8:30 a.m. ET).
- Review the press release furnished as Exhibit 99.1 for any preliminary details not included in the 8-K text.
- Monitor the company's website or investor relations portal for the actual financial results to be presented on the call date.
- Confirm the trading symbol (JAGX) and exchange (Nasdaq Capital Market) for accurate stock tracking.